All Rimjhim Agarwal articles
-
NewsT cells take aim at Chikungunya virus
A new study offers the first-ever map of which parts of Chikungunya virus trigger the strongest response from the body’s T cells, bringing researchers closer to developing Chikungunya vaccines or therapies that harness T cells to strike specific targets to halt infection.
-
NewsScientists uncover key clues to how a viral infection can lead to arthritis-like disease
By studying Chikungunya virus, scientists have shed light on how immune responses to viral infections may lead to persistent symptoms of autoimmune disease.